Mentice AB (publ) (STO:MNTC)

Market Cap	431.73M -29.4%
Revenue (ttm)	284.59M -2.5%
Net Income	-32.33M
EPS	-1.15
Shares Out	28.13M
PE Ratio	n/a
Forward PE	146.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	160
Average Volume	4,416
Open	14.90
Previous Close	15.35
Day's Range	14.90 - 15.00
52-Week Range	8.50 - 22.90
Beta	0.31
RSI	68.35
Earnings Date	Feb 2, 2026

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patie...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 128
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2025, Mentice AB's revenue was 284.59 million, a decrease of -2.48% compared to the previous year's 291.81 million. Losses were -32.33 million, 75.5% more than in 2024.